Literature DB >> 16900205

Cardiovascular drug use and the incidence of erectile dysfunction.

R Shiri1, J Koskimäki, J Häkkinen, A Auvinen, T L J Tammela, M Hakama.   

Abstract

It is unclear whether high blood pressure per se or antihypertensive drug use causes erectile dysfunction (ED). The aim of this study was to investigate the effect of cardiovascular diseases and their concomitant medications use on the incidence of ED. The target population consisted of men aged 55, 65 or 75 years old residing in the study area in Finland in 1999. Questionnaires were mailed to 2837 men in 1999 and to 2510 of them 5 years later. The follow-up sample consisted of 1665 men (66% of those eligible) who responded to both baseline and follow-up questionnaires. Men free of moderate or severe ED at baseline (N=1000) were included in the study. ED was assessed by two questions on subject ability to achieve or maintain an erection sufficient for intercourse. Poisson regression model was used in the multivariable analyses. The risk of ED was higher in men suffering from treated hypertension or heart disease than in those with the untreated condition. The risk of ED was higher in men using calcium channel inhibitor (adjusted relative risk (RR)=1.6, 95% confidence interval (CI) 1.0-2.4), angiotensin II antagonist (RR=2.2, 95% CI 1.0-4.7), non-selective beta-blocker (RR=1.7, 95% CI 0.9-3.2) or diuretic (RR=1.3, CI 0.7-2.4) compared with non-users. ED was not associated with using organic nitrates, angiotensin-converting enzyme inhibitors, selective beta-blockers and serum lipid-lowering agents. In summary, calcium channel inhibitors, angiotensin II antagonists, non-selective beta-blockers and diuretics may increase the risk of ED.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900205     DOI: 10.1038/sj.ijir.3901516

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  6 in total

1.  Cardiovascular drugs and erectile dysfunction - a symmetry analysis.

Authors:  Lotte Rasmussen; Jesper Hallas; Kenneth Grønkjaer Madsen; Anton Pottegård
Journal:  Br J Clin Pharmacol       Date:  2015-07-28       Impact factor: 4.335

Review 2.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

3.  Common prescription medication use and erectile dysfunction: results from the Boston Area Community Health (BACH) survey.

Authors:  Varant Kupelian; Susan A Hall; John B McKinlay
Journal:  BJU Int       Date:  2013-07-02       Impact factor: 5.588

Review 4.  Clinical significance of erectile dysfunction developing after acute coronary event: exception to the rule or confirmation of the artery size hypothesis?

Authors:  Piero Montorsi; Paolo M Ravagnani; Charalambos Vlachopoulos
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

5.  A side effect resource to capture phenotypic effects of drugs.

Authors:  Michael Kuhn; Monica Campillos; Ivica Letunic; Lars Juhl Jensen; Peer Bork
Journal:  Mol Syst Biol       Date:  2010-01-19       Impact factor: 11.429

Review 6.  Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.

Authors:  Dimitrios Terentes-Printzios; Nikolaos Ioakeimidis; Konstantinos Rokkas; Charalambos Vlachopoulos
Journal:  Nat Rev Cardiol       Date:  2021-07-30       Impact factor: 32.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.